Somatic Systems Stock Analysis
| SMAS Stock | USD 0.0001 0.00 0.00% |
200 Day MA 0.0001 | 50 Day MA 0.0001 | Beta (272.30) |
Short and Long Term Debt is likely to drop to about 357.7 K in 2026. Short Term Debt is likely to drop to about 357.7 K in 2026 Somatic Systems' financial risk is the risk to Somatic Systems stockholders that is caused by an increase in debt.
Total Stockholder Equity is likely to drop to about (309.2 K) in 2026. Common Stock is likely to drop to about 400.6 K in 2026. Somatic Systems is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Somatic Systems stock analysis is to determine its intrinsic value, which is an estimate of what Somatic Systems is worth, separate from its market price. There are two main types of Somatic Systems' stock analysis: fundamental analysis and technical analysis.
The Somatic Systems stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Somatic Systems is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day ( substitute day ), Independence Day. Somatic Stock trading window is adjusted to America/New York timezone.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Somatic Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. Somatic Stock Analysis Notes
The company had not issued any dividends in recent years. Somatic Systems had 1:20 split on the 18th of February 2004. Somatic Systems, Inc. provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and pain relief. The company was founded in 1987 and is based in Northampton, Massachusetts with additional offices in Virginia Beach, Virginia and New York, New York. Somatic Systems is traded on OTC Exchange in the United States. To find out more about Somatic Systems contact Steven Aronstein at 413 586 2555 or learn more at https://www.somatics.org.Somatic Systems Quarterly Total Revenue |
|
Somatic Systems Investment Alerts
| Somatic Systems generated a negative expected return over the last 90 days | |
| Somatic Systems has some characteristics of a very speculative penny stock | |
| Somatic Systems currently holds 353.61 K in liabilities. Somatic Systems has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Somatic Systems' use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 107.42 K. Net Loss for the year was (239.08 K) with profit before overhead, payroll, taxes, and interest of 97.66 K. | |
| Somatic Systems currently holds about 7.67 K in cash with (199.9 K) of positive cash flow from operations. | |
| Latest headline from news.google.com: FinancialContent - Somatic Superpowers New Bilingual Guide Launches Nervous System Reset with Polyvagal Tools for Trauma Healing, Anxiety Management, and Lasting Resilience - FinancialContent |
Somatic Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.46 M.Somatic Profitablity
The company has Profit Margin (PM) of (2.23) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (4.97) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $4.97.Management Efficiency
Total Assets is likely to drop to about 197.9 K in 2026. Net Tangible Assets is likely to drop to about (309.2 K) in 2026Somatic Systems' management efficiency ratios could be used to measure how well Somatic Systems manages its routine affairs as well as how well it operates its assets and liabilities.Evaluating the management effectiveness of Somatic Systems allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The Somatic Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Somatic Systems, as well as the relationship between them.Somatic Systems Price Movement Analysis
The output start index for this execution was fourty-nine with a total number of output elements of twelve. The Moving Average is predictive technique used to analyze Somatic Systems price data points by creating a series of averages of different subsets of Somatic Systems entire price series.
Somatic Systems Financial Rating
Somatic Systems financial ratings play a critical role in determining how much Somatic Systems have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Somatic Systems' borrowing costs.| Beneish M Score | (4.67) | Unlikely Manipulator | View |
Somatic Systems Debt to Cash Allocation
Many companies such as Somatic Systems, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Somatic Systems currently holds 353.61 K in liabilities. Somatic Systems has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Somatic Systems' use of debt, we should always consider it together with its cash and equity.Somatic Systems Total Assets Over Time
Somatic Systems Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Somatic Systems' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Somatic Systems, which in turn will lower the firm's financial flexibility.Somatic Short Long Term Debt
Short Long Term Debt |
|
About Somatic Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Somatic Systems prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Somatic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Somatic Systems. By using and applying Somatic Stock analysis, traders can create a robust methodology for identifying Somatic entry and exit points for their positions.
Somatic Systems, Inc. provides drug-free and non-surgical approach to movement disorders, musculoskeletal problems, and pain relief. The company was founded in 1987 and is based in Northampton, Massachusetts with additional offices in Virginia Beach, Virginia and New York, New York. Somatic Systems is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Somatic Systems to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Additional Tools for Somatic Stock Analysis
When running Somatic Systems' price analysis, check to measure Somatic Systems' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Somatic Systems is operating at the current time. Most of Somatic Systems' value examination focuses on studying past and present price action to predict the probability of Somatic Systems' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Somatic Systems' price. Additionally, you may evaluate how the addition of Somatic Systems to your portfolios can decrease your overall portfolio volatility.